Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Yanxin  [Clear All Filters]
2024
Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, Li S, Chen G, Chen C, Li Y, et al. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling. Mol Cancer. 2024;23(1):60.
2023
Xiao H, Wang S, Tang Y, Li S, Jiang Y, Yang Y, Zhang Y, Han Y, Wu X, Zheng L, et al. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance. Int J Cancer. 2023.
Yang Y, Wang S, Cai J, Liang J, Zhang Y, Xie Y, Luo F, Tang J, Gao Y, Shen S, et al. Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity. Cell Oncol (Dordr). 2023.
Wang W, Li X, Qin X, Miao Y, Zhang Y, Li S, Yao R, Yang Y, Yu L, Zhu H, et al. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity. Br J Haematol. 2023.
Li S, Feng T, Zhang Y, Shi Q, Wang W, Ren J, Shen G, Gu H, Luo C, Li Y. Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration. J Ethnopharmacol. 2023:117467.
Li Y, Li Z, Wang C, Yang M, He Z, Wang F, Zhang Y, Li R, Gong Y, Wang B, et al. Spatiotemporal transcriptome atlas reveals the regional specification of the developing human brain. Cell. 2023.
Shi Q, Yu B, Zhang Y, Yang Y, Xu C, Zhang M, Chen G, Luo F, Sun B, Yang R, et al. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex. Cell Oncol (Dordr). 2023.
2022
Li Y, Li Z, Yang M, Wang F, Zhang Y, Li R, Li Q, Gong Y, Wang B, Fan B, et al. Decoding the temporal and regional specification of microglia in the developing human brain. Cell Stem Cell. 2022.
Chen K, Andrade-Barazarte H, Liang W, Zhu Q, Guo H, Li Y, Li H, Qian R. Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review. Medicine (Baltimore). 2022;101(52):e32477.
Yang Y, Wang S, Cai J, Liang J, Zhang Y, Xie Y, Luo F, Tang J, Gao Y, Shen S, et al. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity. Cell Oncol (Dordr). 2022.
2021
Li T, Zhang Y, Li Y, Wang X, Bao W, Huang J, Ma Y, Li S, Wang S, Yang Y, et al. Modeling leukemia with pediatric acute leukemia patient-derived iPSCs. Stem Cell Res. 2021;54:102404.
Yang Y, Song L, Huang X, Feng Y, Zhang Y, Liu Y, Li S, Zhan Z, Zheng L, Feng H, et al. PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. Aging (Albany NY). 2021;12.
2020
Li Y, Li T, Tang Y, Zhan Z, Ding L, Song L, Yu T, Yang Y, Ma J, Zhang Y, et al. The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient. PLoS One. 2020;15(6):e0234262.
2019
Wang Y, Hou Y, Zhang W, Alvarez AA, Bai Y, Hu B, Cheng S-Y, Yang K, Li Y, Feng H. Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response. J Exp Clin Cancer Res. 2019;38(1):147.
2015
Gao Y, Yang P, Shen H, Yu H, Song X, Zhang L, Zhang P, Cheng H, Xie Z, Hao S, et al. Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells. Nat Commun. 2015;6:6328.